Current Edition

Driving sci-tech growth in the UK regions
Volume 2 Issue 2

Driving Sci-tech Growth in the UK Regions

The UK has a long-standing reputation as a world leader in the research and development of new medicines and for operating a high-quality life sciences …

Continue Reading →
Betting on the bug_how the microbiome can
Volume 2 Issue 2

Betting on the Bug: How the Microbiome Can Improve Reproducibility and Translatability

Investigators continually seek to improve the reproducibility of their results and the translatability of their preclinical work, while recognising that both goals pose challenges. In …

Continue Reading →
Key challenges and potential solution for
Volume 2 Issue 2

Key Challenges and Potential Solutions for Optimising Downstream Bioprocessing Production

The term “optimise” is often applied to complex manufacturing, automation and business processes and implies that the most efficient function of all the elements of …

Continue Reading →
Gene therapy_bubble boy and beyond
Volume 2 Issue 2

Gene Therapy: Bubble Boy and Beyond

Gene therapy, which is the delivery of DNA or RNA into cells to treat disease, is at the cutting edge of medical research, and often …

Continue Reading →
Changing state of clinical trials
Volume 2 Issue 2

Changing State of Clinical Trials in the Digital Era

The life sciences industry is undergoing a fundamental change in its business model. The shifts from blockbuster drug to precision medicine and from volume-based to …

Continue Reading →